Product Images Fenofibrate
View Photos of Packaging, Labels & Appearance
Product Label Images
The following 3 images provide visual information about the product associated with Fenofibrate NDC 60505-3121 by Apotex Corp., such as packaging, labeling, and the appearance of the drug itself. This resource could be helpful for medical professionals, pharmacists, and patients seeking to verify medication information and ensure they have the correct product.
LBL130mg30s - LBL130mg30s
Fenofibrate Capsules, USP is a medication that comes in a container of 30 capsules, with each capsule containing 130 mg of micronized Fenofibrate, USP. The medication should be stored at controlled room temperature (20°C to 25°C) in a tight container. The manufacturing company is Apotex Inc., located in Toronto, Ontario, Canada, and it is marketed by Apotex Corp., based in Weston, Florida.*
LBL43mg30s - LBL43mg30s
This is a description of Fenofibrate capsules, USP which contains 43 mg of micronized Fenofibrate per capsule. The recommended storage temperature is between 20°C to 25°C (68°F to 77°F) with permitted excursions between 10°C to 30°C (59°F to 86°F) as per USP Controlled Room Temperature. It is advised to dispense the capsules in a tight container. The usual dosage information can be found in the package insert. The product is manufactured by Apotex Corp and is available in a pack of 30 capsules with NDC code 60505-3120-3.*
chemical-structure - structure
* The product label images have been analyzed using a combination of traditional computing and machine learning techniques. It should be noted that the descriptions provided may not be entirely accurate as they are experimental in nature. Use the information in this page at your own discretion and risk.